Anthem BioSciences Share Price: Target 2025, 2026, 2030, 2035, 2040, 2050

If you invest in the stock market, you must know the Anthem BioSciences share price target 2025, 2026, 2027, 2028, 2029, 2030, 2035, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.

About Anthem BioSciences Ltd

Anthem BioSciences is a top biotech company in India that helps make important products like medicines, vitamins, and health supplements. It works with global pharmaceutical and life sciences companies to develop and manufacture high-quality drugs, enzymes, and other biotech solutions. Anthem uses advanced research and modern labs to create safe and effective products for healthcare, nutrition, and wellness. Its services include custom pharmaceutical manufacturing, contract research, and biotech product development, making it a trusted partner in the pharmaceutical and biotechnology industry. Many big healthcare brands rely on Anthem BioSciences for their R&D and large-scale production needs.

Fundamental Analysis of Anthem BioSciences

Also Read: Dr. Reddy Share Price Target

Anthem BioSciences Share Price Target Tomorrow

Anthem BioSciences Share Price Target 2025

After analysing past price trends and market performance, it is estimated that the Anthem BioSciences stock price could reach a minimum of ₹740 and potentially achieve a maximum target of ₹780 in the year 2025.

Anthem BioSciences Share Price Target 2026

After analysing past price trends and market performance, it is estimated that the Anthem BioSciences stock price could reach a minimum of ₹790 and potentially achieve a maximum target of ₹830 in the year 2026.

Anthem BioSciences Share Price Target 2027

After analysing past price trends and market performance, it is estimated that the Anthem BioSciences stock price could reach a minimum of ₹840 and potentially achieve a maximum target of ₹890 in the year 2027.

Anthem BioSciences Share Price Target 2028

After analysing past price trends and market performance, it is estimated that the Anthem BioSciences stock price could reach a minimum of ₹900 and potentially achieve a maximum target of ₹950 in the year 2028.

Anthem BioSciences Share Price Target 2029

After analysing past price trends and market performance, it is estimated that the Anthem BioSciences stock price could reach a minimum of ₹960 and potentially achieve a maximum target of ₹1010 in the year 2029.

Anthem BioSciences Share Price Target 2030

After analysing past price trends and market performance, it is estimated that the Anthem BioSciences stock price could reach a minimum of ₹1020 and potentially achieve a maximum target of ₹1080 in the year 2030.

Also Read: Glenmark Pharmaceuticals Share Price Target

Shareholding Pattern of Anthem BioSciences

Should You Invest in Anthem BioSciences Stock?

Whether you should invest or not, it depends on the many factors. Let us know the risk and opportunities to invest in Anthem BioSciences stock.

Opportunities

• Anthem BioSciences works in the fast-growing biotech and pharma research sector, which has strong long-term growth potential.
• The company offers contract research and manufacturing (CRAMS) services, a popular and rising segment in the healthcare industry.
• It focuses on new drug discovery and formulation development, which can lead to future high profits.
• Anthem serves both domestic and international clients, helping it gain global revenue exposure.
• The company benefits from India’s low-cost, high-skill research ecosystem, making its services competitive and profitable.

Risks

• Anthem BioSciences is not a listed company yet, so it’s hard to track real-time performance and financial updates.
• The biotech industry has long research cycles, which can delay profits and affect stock value.
• Business depends heavily on regulatory approvals from global health agencies, which can cause project delays.
• Any failure in drug trials or research projects may lead to big financial losses.
• Anthem faces strong competition from large pharma and research companies, which can limit market share and pricing power.

Key Competitors of Anthem BioSciences

Key competitors or peer companies of Anthem BioSciences are Cipla, Dr. Reddy’s Laboratories, Divi’s Laboratories, Biocon, Laurus Labs, Piramal Pharma Solutions, Glenmark Life Sciences, Syngene International, Jubilant Biosys, Aurobindo Pharma, GVK BioSciences, Sun Pharma, Lupin Limited, Zydus Lifesciences, and Strides Pharma Science.

Also Read: Piramal Pharma Share Price Target

FAQs

Team DateUpdateGo

We have more than 5 years of experience in stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.